This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Il Dong Pharmaceutical Co., Ltd., Ildong Pharm Co., Ltd., Idience Co., Ltd.. Active years: 2017-2024.
Location History:
- Gyeonggi-do, KR (2017 - 2022)
- Hwaseong-si, KR (2021 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: Yoon-Suk Lee: Innovator in Pharmaceutical Compounds
Introduction
Yoon-Suk Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on developing innovative compounds that address various medical conditions.
Latest Patents
Among his latest patents, Yoon-Suk Lee has developed autotaxin (ATX) inhibitor compounds. This patent provides compositions that include these compounds and outlines methods for using them to inhibit ATX. Additionally, he has created isoxazole derivatives that serve as nuclear receptor agonists. This invention offers methods for treating metabolic diseases, cholestatic liver diseases, and organ fibrosis through the administration of a therapeutically effective amount of a pharmaceutical composition.
Career Highlights
Yoon-Suk Lee has worked with notable companies in the pharmaceutical industry, including Il Dong Pharmaceutical Co., Ltd. and Ildong Pharm Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Yoon-Suk Lee has collaborated with talented individuals such as Kyung-Sun Kim and Dong-Keun Song. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.
Conclusion
Yoon-Suk Lee's contributions to the pharmaceutical field through his innovative patents and collaborations highlight his role as a key inventor. His work continues to impact the development of treatments for various medical conditions.